Paladin Technologies, a firm engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases, completed the acquisition of Commercial Security Integration, a provider of security systems integration services. Financial terms were not disclosed. “Aligning with CSI has immediately enhanced the depth of our US security division. CSI held Paladin’s philosophies of teamwork and a client-focused vision which made them a perfect team to bring into our group of companies. We are excited that with CSI’s strategic alliances, our clients will benefit from the highest quality solutions. Paladin Technologies remains committed to expanding our reach across North America to make lasting impact on our industry," Ted Reid, Paladin CEO.